| 发明名称 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES OR FATTY LIVER CONTAINING A CYP4A INHIBITOR AS AN ACTIVE INGREDIENT |
| 摘要 |
The present invention relates to a pharmaceutical composition for preventing or treating diabetes or fatty liver, and more specifically relates to a pharmaceutical composition for preventing or treating diabetes or fatty liver containing a CYP4A (cytochrome P450A) inhibitor as an active ingredient. According to the present invention, the CYP4A inhibitor suppresses endoplasmic reticulum stress, reduces the blood insulin concentration and suppresses apoptosis of liver cells, and hence exhibits effects in preventing or treating diabetes or fatty liver. |
| 申请公布号 |
US2014275198(A1) |
申请公布日期 |
2014.09.18 |
| 申请号 |
US201414178090 |
申请日期 |
2014.02.11 |
| 申请人 |
Korea Basic Science Institute |
发明人 |
Kim Gun-Hwa;Kim Soohyun;Choi Jong-Soon;Kim Seung II;Park Edmond Changkyun |
| 分类号 |
A61K31/4192;A61K31/4174;A61K31/201;A61K31/15;A61K31/18 |
主分类号 |
A61K31/4192 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition for preventing or treating diabetes or fatty liver comprising a CYP4A. (cytochrome P450 4A) inhibitor as an active ingredient. |
| 地址 |
Daejeon KR |
